IS6713A - Framleiðsla risperídóns - Google Patents

Framleiðsla risperídóns

Info

Publication number
IS6713A
IS6713A IS6713A IS6713A IS6713A IS 6713 A IS6713 A IS 6713A IS 6713 A IS6713 A IS 6713A IS 6713 A IS6713 A IS 6713A IS 6713 A IS6713 A IS 6713A
Authority
IS
Iceland
Prior art keywords
risperidone
production
disclosed
methods
present
Prior art date
Application number
IS6713A
Other languages
English (en)
Icelandic (is)
Inventor
Krochmal Barnaba
Diller Dov
Dolitzky Ben-Zion
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26919535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6713(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS6713A publication Critical patent/IS6713A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS6713A 2000-08-14 2003-02-11 Framleiðsla risperídóns IS6713A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22536100P 2000-08-14 2000-08-14
US24326300P 2000-10-25 2000-10-25
PCT/US2001/025387 WO2002014286A1 (en) 2000-08-14 2001-08-14 Preparation of risperidone

Publications (1)

Publication Number Publication Date
IS6713A true IS6713A (is) 2003-02-11

Family

ID=26919535

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6713A IS6713A (is) 2000-08-14 2003-02-11 Framleiðsla risperídóns

Country Status (20)

Country Link
US (2) US6750341B2 (OSRAM)
EP (2) EP1317434A4 (OSRAM)
JP (3) JP3751942B2 (OSRAM)
KR (2) KR100818875B1 (OSRAM)
AT (1) ATE401313T1 (OSRAM)
AU (1) AU2001284880A1 (OSRAM)
CA (1) CA2419314C (OSRAM)
CZ (1) CZ2003668A3 (OSRAM)
DE (1) DE60134899D1 (OSRAM)
ES (1) ES2310410T3 (OSRAM)
HR (1) HRP20030154B1 (OSRAM)
HU (1) HUP0302874A2 (OSRAM)
IL (2) IL154417A0 (OSRAM)
IS (1) IS6713A (OSRAM)
MX (1) MXPA03001337A (OSRAM)
NZ (1) NZ524554A (OSRAM)
PL (1) PL365608A1 (OSRAM)
PT (1) PT1783118E (OSRAM)
SK (1) SK2982003A3 (OSRAM)
WO (1) WO2002014286A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
WO2004020439A2 (en) * 2002-08-30 2004-03-11 Sunil Sadanand Nadkarni Improved process for preparation of risperidone
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
WO2004043923A1 (en) 2002-11-13 2004-05-27 Synthon B.V. Process for making risperidone and intermediates therefor
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
WO2004092143A1 (en) * 2003-04-16 2004-10-28 Hetero Drugs Limited A novel crystalline form of risperidone
HUE051230T2 (hu) 2003-10-16 2021-03-01 Symed Labs Ltd Linezolid kristályos formája
EP2633853A1 (en) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
ES2294494T3 (es) * 2004-04-19 2008-04-01 Symed Labs Limited Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
HUP0401379A3 (en) * 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
WO2006029192A1 (en) * 2004-09-08 2006-03-16 Dermatrends, Inc. Transdermal delivery of hydrophobic bioactive agents
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
US20090075974A1 (en) * 2005-04-27 2009-03-19 Umn Pharma Inc. Agent for prophylaxis and treatment of pancreatitis
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007093870A2 (en) * 2006-02-15 2007-08-23 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of risperidone
US7820816B2 (en) * 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
WO2008153611A2 (en) 2007-05-25 2008-12-18 Qlt Usa, Inc. Sustained delivery formulations of risperidone compounds
EP3006024B1 (en) 2009-01-20 2019-03-20 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Benzoic acid or salts thereof to enhance the activity of a neuropharmaceutical
CN102786521B (zh) * 2011-05-18 2016-01-13 中国医学科学院药物研究所 利培酮晶iii型物质及制备方法与在药品和保健品中应用
CN105367570B (zh) * 2015-12-08 2017-10-10 天津市亨必达化学合成物有限公司 一种利培酮晶i型物质的制备方法
KR102488927B1 (ko) 2016-06-13 2023-01-13 신유알엑스 인터내셔널 (타이완) 코포레이션 벤조산리튬의 공-결정 및 그의 용도
TWI671287B (zh) 2016-06-13 2019-09-11 心悅生醫股份有限公司 苯甲酸鈉之共晶及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
ES2050069B1 (es) 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
JP2000503986A (ja) * 1996-01-26 2000-04-04 ファルマシア・アンド・アップジョン・カンパニー Ｈｉｖ―１陽性であるヒトにおけるデラビルジンおよびプロテアーゼ・インヒビターの使用
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
EP1280804B1 (en) 2000-05-05 2004-04-14 RPG Life Sciences Limited A process for the preparation of anti-psychotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one
WO2002012200A1 (en) * 2000-08-08 2002-02-14 Teva Pharmaceutical Industries Ltd. Preparation of risperidone
US20020193386A1 (en) 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof

Also Published As

Publication number Publication date
EP1982980A1 (en) 2008-10-22
KR20030022389A (ko) 2003-03-15
IL154417A0 (en) 2003-09-17
KR20080028513A (ko) 2008-03-31
MXPA03001337A (es) 2005-06-30
DE60134899D1 (de) 2008-08-28
HUP0302874A2 (hu) 2003-12-29
US20040229905A1 (en) 2004-11-18
HRP20030154A2 (en) 2005-04-30
ATE401313T1 (de) 2008-08-15
US6750341B2 (en) 2004-06-15
CA2419314A1 (en) 2002-02-21
JP2006028192A (ja) 2006-02-02
AU2001284880A1 (en) 2002-02-25
WO2002014286A9 (en) 2003-03-27
US7256195B2 (en) 2007-08-14
HRP20030154B1 (en) 2009-03-31
JP2004506622A (ja) 2004-03-04
EP1317434A1 (en) 2003-06-11
IL154417A (en) 2008-11-03
ES2310410T3 (es) 2009-01-01
EP1317434A4 (en) 2005-06-22
CZ2003668A3 (en) 2004-04-14
KR100818875B1 (ko) 2008-04-01
NZ524554A (en) 2005-07-29
JP2008056699A (ja) 2008-03-13
CA2419314C (en) 2006-07-11
PL365608A1 (en) 2005-01-10
SK2982003A3 (en) 2004-10-05
JP3751942B2 (ja) 2006-03-08
US20020115673A1 (en) 2002-08-22
WO2002014286A1 (en) 2002-02-21
PT1783118E (pt) 2008-08-19

Similar Documents

Publication Publication Date Title
IS6713A (is) Framleiðsla risperídóns
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
ATE334662T1 (de) Herstellungsverfahren von arzneizubereitungen
WO2002055501A3 (en) N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
ATE361288T1 (de) N-(3,-dimethylindolin-6-yl)ä2-ä(4-
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
HUP0402560A2 (hu) N-(Adamantil-metil)-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
MEP9509A (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
IS6859A (is) Kristölluð form atorvastatíns
HUP0204235A2 (hu) Helyettesített glutárimidek és felhasználásuk IL-12 termelés inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
GB0003154D0 (en) Novel compounds
MXPA03001431A (es) Polimeros de un analogo de epotilona.
CY1108085T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπ-2-εν-1-ονης παρασκευη και χρησης αυτων
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
SE0100569D0 (sv) New compounds
WO2005063764A3 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
MXPA04000847A (es) Procedimiento para la obtencion de beraprost y sus sales.
WO2002076438A3 (en) Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
DK1525188T3 (da) Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem
WO2001081298A3 (en) Cyclic carboxylic acids as integrin antagonists
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MEP56208A (en) Caloporoside derivatives, methods for the production thereof and their use
CA2535742A1 (en) Preparation of risperidone